| Family: | Langar Investment |
| Name: | Langar Global Healthtech ETF |
| Inception Date: | 10-Jan-2024 |
| Termination Date: | |
| Investment Objective: | Langar Global HealthTech ETF (the "Fund") seeks long-term growth of capital. As an actively managed ETF, the Fund will not seek to replicate the performance of an index. The Fund intends to achieve its investment objective by investing a majority of its net assets in U.S. and foreign exchange-listed healthcare technology companies in the U.S and a number of developed countries around the world. Under normal circumstances, the Fund will invest at least 80% of the Fund's net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts ("ADRs") on those securities. These securities may be of any market capitalization. |
| Prospectus | |
| Top 10 Holdings | ||
| INTUITIVE SURGICAL INC | ISRG | 16.2500% |
| RESMED INC | RMD | 9.7000% |
| GE HEALTHCARE TECHNOLOGIES INC | GEHC | 9.3900% |
| VEEVA SYSTEMS INC | VEEV | 8.4400% |
| INSULET CORP | PODD | 7.6500% |
| IQVIA HOLDINGS INC | IQV | 7.1600% |
| PHILIPS ELECTRONICS-NY SHR | PHG | 5.6200% |
| SIEMENS HEALTHINEE-UNSP ADR | SMMNY | 4.7300% |
| DEXCOM INC | DXCM | 4.6000% |
| ZIMMER BIOMET HOLDINGS INC | ZBH | 3.7100% |
| Top 10 Holdings Weight: | 77.3% |
| Number of Holdings: | 31 |
| Shares Outstanding: | 400,000 |
| Total Net Assets: | 4,183,360 |
| NAV: | 10.45 |
| Net Expense Ratio: | 0.85% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Biotech |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Global |
